Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a small, open label pilot study comparing upper and lower GI routes of administration did not show any differences44”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [44]
In the citing paper
“The human gut microbiota can restrict the growth of pathogens to prevent them from colonizing the intestine (‘colonization resistance’).”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
In the citing paper
“Gut microbiota with high diversity have higher colonization resistance than gut microbiota with low diversity as a result of antibiotic treatment [28].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
Citations
Cites
Measuring biological diversity
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,621
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 3×
“exist in a complex symbiosis with their host [5].”
BackgroundInfluentialSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501 · cited 1×
“The distance matrix was fed into DOTUR [8] to group the sequences into operational taxonomic units (OTUs), calculate ecological diversity measures (including the Shannon index [9]), and generate rarefaction curves by use of an OTU definition of 97% sequence similarity.”
MethodAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 1×
“Diarrhea is a common side effect of the administration of antibiotics, with Clostridium difficile being responsible for most of the severe cases of antibiotic-associated diarrhea (AAD), including the development of pseudomembranous colitis [1].”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundKyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804 · cited 1×
“difficile toxin [11].”
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundAas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518 · cited 1×
“individuals to patients with RCD [4, 15]—is to alter the patient’s microbiome and to restore colonization resistance.”
BackgroundBACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“microbiota is that of “colonization resistance” [10].”
Cited by
Items 401–500 of 999
Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota
Gu, S., Gong, Y., Zhang, J., Chen, Y., Wu, Z., Xu, Q., Fang, Y., Wang, J., & Tang, L. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s281274 · Cited by 47
Guan, Y., Zhang, H., Gao, X., Shang, S., Wu, X., Chen, J., Zhang, W., Zhang, W., Jiang, M., Zhang, B., et al. (2016) · AMB Express · doi:10.1186/s13568-016-0254-4 · Cited by 44
Matzaras, R., Nikopoulou, A., Protonotariou, E., & Christaki, E. (2022) · PubMed Central · Cited by 77
The Ecology and Pathobiology of Clostridium difficile Infections: An Interdisciplinary Challenge
Dubberke, E. R., Haslam, D. B., Lanzas, C., Bobo, L. D., Burnham, C. D., Grohn, Y. T., & Tarr, P. I. (2010) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2010.01352.x · Cited by 46
“CDI stools have less overall bacterial diversity than control stools, as assessed by 16S rRNA gene sequencing (Chang et al., 2008).”
MethodBest Strategies in Recurrent or Persistent Clostridium difficile Infection
Cocanour, C. S. (2011) · Surgical Infections · doi:10.1089/sur.2010.080 · Cited by 42
“Patients with only an initial episode of CDI and control patients have a predominance of Bacteroides and Firmicutes, whereas patients who develop recurrent CDI have significantly less diversity [24].”
Clostridium difficile infection in diabetes
Qu, H., & Jiang, Z. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.06.002 · Cited by 44
Soriano, M. M., Danziger, L. H., Gerding, D. N., & Johnson, S. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu069 · Cited by 41
“rent CDI as well as primary CDI [17, 18].”
BackgroundCorbett, D. F., Wise, A., Birchall, S., Warn, P. A., Baines, S. D., Crowther, G. S., Freeman, J., Chilton, C. H., Vernon, J. J., Wilcox, M. H., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv006 · Cited by 45
Muletz‐Wolz, C. R., DiRenzo, G. V., Yarwood, S. A., Grant, E. H. C., Fleischer, R. C., & Lips, K. R. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.00186-17 · Cited by 43
Iqbal, U., Anwar, H., & Karim, M. A. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001147 · Cited by 45
Lin, S. C., Alonso, C. D., & Moss, A. C. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12967 · Cited by 44
Temporal Variability and Stability of the Fecal Microbiome: The Multiethnic Cohort Study
Fu, B. C., Randolph, T. W., Lim, U., Monroe, K. R., Cheng, I. C., Wilkens, L. R., Marchand, L. L., Lampe, J. W., & Hullar, M. A. J. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0348 · Cited by 45
“Factors such as diet (11–14), use of antibiotics and other medications (15, 16), and exposure to pathogens (17) can have a pronounced impact on bacteria residing in the gut and other anatomical sites.”
BackgroundNLRP3 and Gut Microbiota Homeostasis: Progress in Research
Pan, H., Jian, Y., Wang, F., Yu, S., Guo, J., Kan, J., & Guo, W. (2022) · Cells · doi:10.3390/cells11233758 · Cited by 44
“difficile infection was significantly reduced [29].”
The Human Microbiome and Probiotics: Implications for Pediatrics
Hsieh, M. H., & Versalovic, J. A. (2008) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2008.09.001 · Cited by 56
Romanelli, C., Cooper, H. D., & B.F., B. F. D. S. D. (2014) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.33.2.2291 · Cited by 49
“Such studies support the conclusion that preserving and restoring microbial communities may have important implications for the development of novel public health strategies and alternative therapies (38), and could reduce the transmission and prevalence of non-communicable diseases, including chronic diseases (31, 33…”
Backgroundvan Opstal, E. J., Kolling, G. L., Moore, J. H., Coquery, C. M., Wade, N. S., Loo, W. M., Bolick, D. T., Shin, J. H., Erickson, L. D., & Warren, C. A. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw071 · Cited by 43
“Immunosenescence, or the effect of aging on the immune system, may potentially affect the outcome of CDI.”
ResultInfluentialVillageliú, D. N., & Lyte, M. (2017) · Poultry Science · doi:10.3382/ps/pex148 · Cited by 48
Cabral, D. J., Wurster, J. I., Korry, B. J., Penumutchu, S., & Belenky, P. A. (2020) · mSystems · doi:10.1128/msystems.00317-20 · Cited by 48
“Most notably, broad-spectrum antibiotic treatment is a major risk factor in Clostridioides difficile infection (20, 22, 25, 26).”
BackgroundNooij, S., Ducarmon, Q. R., Laros, J. F. J., Zwittink, R. D., Norman, J. M., Smits, W. K., Verspaget, H. W., Keller, J. J., Terveer, E. M., & Kuijper, E. J. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.009 · Cited by 39
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 58
“The repetitive administration of antibiotics is frequently required to manage recurring CDI, resulting in additional disturbance to the equilibrium of the microbiota (Chang et al., 2008; Hamilton et al., 2012).”
Malik, U., Armstrong, D., Ashworth, M., Dregan, A., L’Esperance, V., McDonnell, L., Molokhia, M., & White, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx374 · Cited by 39
Influence of Altered Gut Microbiota Composition on Aging and Aging-Related Diseases
Choi, J., Hur, T.-Y., & Hong, Y. (2018) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2018.8.1.1 · Cited by 38
“Treatment with antibiotics in the human gut affects genetic changes [38], vitamin production [39], digestion [40], microbe diversity [41-43], the immune”
BackgroundYin, N., Li, J., He, Y. Q., Herradura, P. S., Pearson, A. L., Mesleh, M. F., Mascio, C. T. M., Howland, K., Steenbergen, J. N., Thorne, G. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00366 · Cited by 39
Kunishima, H., Ohge, H., Suzuki, H., Nakamura, A., Matsumoto, K., Mikamo, H., Mori, N., Morinaga, Y., Yanagihara, K., Yamagishi, Y., et al. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.12.011 · Cited by 48
Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease
Monaghan, T. M., Cockayne, A., & Mahida, Y. R. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000461 · Cited by 38
“Compared with controls, fecal samples from patients who develop CDI after antibiotic treatment show decreased microbial diversity and exhibit other changes in the microbiota.(110,119,120) Members of the Firmicutes phylum, Lachnospiraceae, and Rumi-”
BackgroundResultLyte, M., Villageliú, D. N., Crooker, B. A., & Brown, D. R. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13589 · Cited by 38
Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection
Adamu, B. O., & Lawley, T. D. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.009 · Cited by 48
“Current Opinion in Microbiology 2013, 16:596–601 increased Proteobacteria and Verrucomicrobia [21].”
BackgroundMethodInfluentialHernández‐Gómez, O., Hoverman, J. T., & Williams, R. N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01379 · Cited by 41
“Importantly, functionality of the host’s symbiont community can correlate with the overall diversity of the microbiome (Chang et al., 2008) or presence of key symbionts (Woodhams et al.”
BackgroundLoss of function dysbiosis associated with antibiotics and high fat, high sugar diet
Miller, A. W., Orr, T. J., Dearing, M. D., & Monga, M. (2019) · The ISME Journal · doi:10.1038/s41396-019-0357-4 · Cited by 40
Aabed, K., Bhat, R. S., Moubayed, N., Al-Mutiri, M., Al-Marshoud, M., Alqahtani, A. M., & El-Ansary, A. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.1.1 · Cited by 44
“Propolis reduces lipid peroxide levels and replenishes GSH levels through inhibiting xanthine oxidase enzyme, reducing ROS generation, scavenging H2O2 and restoring normal Figure 1.”
BackgroundInfluentialMetagenomic Signatures of Gut Infections Caused by Different Escherichia coli Pathotypes
Peña, Á., Soto-Girón, M. J., Smith, S. M., Sistrunk, J. R., Montero, L., Páez, M., Ortega, E., Hatt, J. K., Cevallos, W., Trueba, G. A., et al. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01820-19 · Cited by 42
Frisbee, A. L., & Petri, W. A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.009 · Cited by 46
The role of diet in triggering human inflammatory disorders in the modern age
Huang, E. Y., Devkota, S., Moscoso, D. I., Chang, E. B., & Leone, V. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.07.004 · Cited by 45
Clostridium Difficile Infection from a Surgical Perspective
Kaiser, A. M., Hogen, R., Bordeianou, L., Alavi, K., Wise, P. E., & Sudan, R. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2785-4 · Cited by 40
Oksi, J., Aalto, A., Säilä, P., Partanen, T., Anttila, V., & Mattila, E. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03630-y · Cited by 42
AsymptomaticClostridium difficilecolonization as a reservoir forClostridium difficileinfection
Galdys, A. L., Curry, S. R., & Harrison, L. H. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.920252 · Cited by 41
“Severe CDI has been provoked in an antibiotic-exposed enteric environment that is challenged with a CD load [41–44], and decreased intestinal diversity has been observed in patients with recurrent CDI [45], but the precise mechanism of protection offered by a diverse intestinal microbiome is unclear.”
BackgroundMcMillan, A. S., Zhang, G., Dougherty, M., McGill, S., Gulati, A., Baker, E. S., & Theriot, C. M. (2024) · mSphere · doi:10.1128/msphere.00706-24 · Cited by 44
Management of Clostridium difficile Infection.
Al-Jashaami, L., & DuPont, H. L. (2016) · PubMed Central · Cited by 47
van Beurden, Y. H., Nieuwdorp, M., van de Berg, P. J. E. J., Mulder, C. J. J., & Goorhuis, A. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17690480 · Cited by 36
Faecal microbiota transplantation: a regulatory hurdle?
Verbeke, F., Janssens, Y., Wynendaele, E., & Spiegeleer, B. D. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0687-5 · Cited by 40
Modeling Host-Microbiome Interactions in Caenorhabditis elegans
Gerbaba, T. K., Green-Harrison, L. E., & Buret, A. G. (2017) · Journal of Nematology · doi:10.21307/jofnem-2017-082 · Cited by 42
Mintz, M. J., Khair, S., Grewal, S., LaComb, J. F., Park, J., Channer, B., Rajapakse, R. O., Bucobo, J. C., Buscaglia, J. M., Monzur, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190997 · Cited by 40
Han, S., Guan, Y., Dou, H., Yang, H., Yao, M., Ge, J., & Feng, L. (2019) · PeerJ · doi:10.7717/peerj.6684 · Cited by 39
“, 2015), and the proportion of Proteobacteria was related with inflammatory bowel disorder (IBD) and Clostridium difficile infection (Chang et al., 2008; Packey & Sartor, 2009) as well.”
BackgroundDiversity of key players in the microbial ecosystems of the human body
Jordán, F., Lauria, M., Scotti, M., Nguyen, T.-P., Praveen, P., Morine, M., & Priami, C. (2015) · Scientific Reports · doi:10.1038/srep15920 · Cited by 35
Treatment of Recurrent and Severe Clostridium Difficile Infection
Keller, J. J., & Kuijper, E. J. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-070813-114317 · Cited by 35
New Role for Human α-Defensin 5 in the Fight against Hypervirulent Clostridium difficile Strains
Furci, L., Baldan, R., Bianchini, V., Trovato, A., Ossi, C. M., Cichero, P., & Cirillo, D. M. (2014) · Infection and Immunity · doi:10.1128/iai.02955-14 · Cited by 46
“Disruption of the normal gut microflora by broad-spectrum antibiotics (10) allows C.”
BackgroundEggers, S. I., Malecki, K. M. C., Peppard, P. E., Mares, J. A., Shirley, D. K., Shukla, S. K., Poulsen, K. P., Gangnon, R. E., Duster, M. N., Kates, A., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019450 · Cited by 38
“2 There is no consensus on what microbial composition constitutes a healthy gut microbiota, although a more diverse microbiota is thought to be better, especially in the case of healthy immune response and protection against infection.(3) Infection with multidrug-resistant organisms (MDROs) is increasingly common and…”
BackgroundLi, T., Qi, M., Gatesoupe, F.-J., Tian, D., Jin, W., Li, J., Lin, Q., Wu, S., & Li, H. (2018) · Microbial Ecology · doi:10.1007/s00248-018-1275-0 · Cited by 40
Nagalingam, N. A., Robinson, C. J., Bergin, I. L., Eaton, K. A., Huffnagle, G. B., & Young, V. B. (2013) · Microbiome · doi:10.1186/2049-2618-1-15 · Cited by 35
“; licensee BioMed Ce Creative Commons Attribution License (http:/ distribution, and reproduction in any medium Alteration of microbial community structure has been associated with intestinal diseases in patients and animal models of IBD [4-8].”
BackgroundSelf-citationGut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
Liu, Y., Xu, L., Yang, Z., Wang, D., Li, T., Yang, F., Li, Z., Bai, X., & Wang, Y.-C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114837 · Cited by 34
Control of Clostridium difficile Infection by Defined Microbial Communities
Collins, J., & Auchtung, J. M. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0009-2016 · Cited by 44
Major, G., Bradshaw, L. E., Boota, N., Sprange, K., Diggle, M. A., Montgomery, A. A., Jawhari, A. U., & Spiller, R. E. (2018) · Gut · doi:10.1136/gutjnl-2018-316794 · Cited by 40
Exercise training modifies gut microbiota with attenuated host responses to sepsis in wild‐type mice
Kim, D., & Kang, H. (2019) · The FASEB Journal · doi:10.1096/fj.201802481r · Cited by 39
“Abnormal changes in gut microbiota composition have been implicated in the development of metabolic complications (5), inflammatory bowel disease (6), Clostridium difficile infection (7), colorectal cancer (8), and irritable bowel syndrome (9).”
BackgroundRecurrent Clostridium difficile infection and the microbiome
Almeida, R., Gerbaba, T. K., & Petrof, E. O. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1099-3 · Cited by 39
“Numerous studies have demonstrated decreased intestinal microbial diversity among patients with rCDI compared to those with only one episode of CDI that does not recur [33], and diversity is reduced in patients with primary or rCDI compared to those with asymptomatic colonization [33, 37, 38].”
Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease
Hourigan, S. K., Sears, C. L., & Oliva‐Hemker, M. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000666 · Cited by 38
“By 16s rRNA gene sequencing, those with recurrent CDI compared with control subjects without CDI and those with a single episode of CDI were shown to have a significantly decreased diversity using the Shannon–Weiner diversity index and decreased overall species richness.(25) Moreover, microbiome compositional changes…”
MethodEliakim‐Raz, N., Fishman, G., Yahav, D., Goldberg, E., Stein, G. Y., Zvi, H. B., Barsheshet, A., & Bishara, J. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2348-3 · Cited by 37
“demonstrated that patients with recurrent CDI had decreased species of Bacteroidetes and Firmicutes in their stool compared to patients with just a single episode of CDI [14].”
BackgroundKETERSEDIAAN SARANA SANITASI DASAR, PERSONAL HYGIENE IBU DAN KEJADIAN DIARE
Mafazah, L. (2013) · doi:10.15294/kemas.v8i2.2819 · Cited by 33
Zaheer, R., Dugat‐Bony, É., Holman, D. B., Cousteix, E., Xu, Y., Munns, K. D., Selinger, L. J., Barbieri, R., Alexander, T. W., McAllister, T. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170050 · Cited by 41
“For example, this was observed in patients suffering from diarrhea caused by Clostridium difficile [58, 59], in mice infected with Salmonella enterica [60] or Campylobacter jejuni [61], in TLR5-KO mice infected with adherent-invasive E.”
BackgroundPiątek, J., Krauss, H., Ciechelska-Rybarczyk, A., Bernatek, M., Wojtyła-Buciora, P., & Sommermeyer, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093332 · Cited by 38
“For an initial C. difficile infection (CDI), the exposure to antibiotics is the most important risk factor [37].”
BackgroundInfluentialIn Vitro Prebiotic Effects of Malto-Oligosaccharides Containing Water-Soluble Dietary Fiber
Jang, E. Y., Hong, K., Chang, Y. B., Shin, J.-C., Jung, E. Y., Jo, K., & Suh, H. J. (2020) · Molecules · doi:10.3390/molecules25215201 · Cited by 32
“infection, Crohn’s disease, and obesity [29,30].”
Kassam, Z., Lee, C., & Hunt, R. H. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.08.007 · Cited by 34
Fareed, S., Sarode, N., Stewart, F. J., Malik, A., Laghaie, E., Khizer, S., Yan, F., Pratte, Z. A., Lewis, J. D., & Immergluck, L. C. (2018) · PeerJ · doi:10.7717/peerj.4663 · Cited by 38
“Overall, pre-FMT profiles showed high abundance of Proteobacteria, with low amounts of Bacteroidetes.”
BackgroundEpidemiological and genomic characterization of community-acquired Clostridium difficile infections
Thornton, C. S., Rubin, J. E., Greninger, A. L., Peirano, G., Chiu, C. Y., & Pillai, D. R. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3337-9 · Cited by 35
McLaughlin, R. W., Chen, M., Zheng, J., Zhao, Q., & Wang, D. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1375-0 · Cited by 36
Sofi, A. A., Silverman, A. L., Khuder, S., Garborg, K. K., Westerink, J. M. A., & Nawras, A. T. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.743585 · Cited by 35
“, the composition of gut flora in patients with initial CDI was compared with patients with recurrent CDI and with the healthy controls [39].”
BackgroundFecal Microbiota Transplantation and Its Potential Therapeutic Uses in Gastrointestinal Disorders
Heath, R. D., Cockerell, C., Mankoo, R., Ibdah, J. A., & Tahan, V. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.10692 · Cited by 36
“Overall, however, alterations in the ratio of these groups appear to be associated with various disease states [1-3].”
BackgroundInfluentialTomas, M. E., Mana, T. S. C., Wilson, B. M., Nerandzic, M. M., Joussef-Piña, S., Quiñones‐Mateu, M. E., & Donskey, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02237-17 · Cited by 31
Loo, V. G., Davis, I. R., Embil, J. M., Evans, G. A., Hota, S. S., Lee, C., Lee, T. C., Longtin, Y., Louie, T., Moayyedi, P., et al. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.2018.02.13 · Cited by 48
“of FMTs and response rate (%) 1 (44)* 1 (55) 2 (84) 1 (81) 2 (94) 1 (65) b2 (90) 1 – NG (60) 2 – NG/NG (80) 1 (91) 2 – Colonoscopy and NG (100)† 1 – Colonoscopy (80)”
Murine models to study Clostridium difficile infection and transmission
Lawley, T. D., & Young, V. B. (2013) · Anaerobe · doi:10.1016/j.anaerobe.2013.09.008 · Cited by 31
“difficile infection in humans is a severe outcome in 25e35% of patients that results in chronic diarrhea [24] linked to a pathological imbalance within the intestinal microbiota [25], termed dysbiosis.”
BackgroundSelf-citationAntibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm
Wilcox, M. A., & Crowther, G. S. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s87224 · Cited by 31
“Although all differ from each other on a mechanistic level, most are grounded on the principle of attempting to spare, protect, or repair the endogenous gut flora.(42) The microbiological supplementation approach, notably fecal microbiota transplant and Rebiotix oral preparation (Table 2), addresses the high rates of…”
BackgroundUse of probiotics in prevention and treatment of patients with Clostridium difficile infection
Ollech, J. E., Shen, N. T., Crawford, C. V., & Ringel, Y. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.002 · Cited by 38
Cannon, K., Byrne, B., Happe, J., Wu, K., Ward, L., Chesnel, L., & Louie, T. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx318 · Cited by 31
The gut microbiome in solid organ transplantation
Arassi, M. B., Zeller, G., Karcher, N., Zimmermann, M., & Tönshoff, B. (2020) · Pediatric Transplantation · doi:10.1111/petr.13866 · Cited by 27
The geometry of clinical labs and wellness states from deeply phenotyped humans
Zimmer, A., Kohanim, Y. K., Rappaport, N., Wilmanski, T. M., Baloni, P., Jade, K., Robinson, M., Magis, A. T., Lovejoy, J. C., Gibbons, S. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23849-8 · Cited by 29
Gut microbiota alterations in response to sleep length among African-origin adults
Fei, N., Choo-Kang, C., Reutrakul, S., Crowley, S. J., Rae, D. E., Bedu-Addo, K., Plange‐Rhule, J., Forrester, T., Lambert, E. V., Bovet, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255323 · Cited by 33
Curry, S. R. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.01.007 · Cited by 36
Engevik, M. A., Hickerson, A. T., Shull, G. E., & Worrell, R. T. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356632 · Cited by 33
Vompe, A. D., Epstein, H. E., Speare, K. E., Schmeltzer, E. R., Adam, T. C., Burkepile, D. E., Sharpton, T. J., & Thurber, R. L. V. (2023) · Global Change Biology · doi:10.1111/gcb.17088 · Cited by 32
“…or stresses (e.g., disease outbreaks) follow such patterns, including coral conditions such as “gray-patch disease” in Porites (Sweet et al., 2019), radiation effects on vole gut microbiota (Lavrinienko et al., 2020 ), as well as Clostridium difficile infection in humans (Chang et al., 2008 ).”
BackgroundWang, Y., Hunt, A., Danziger, L. H., & Drwiega, E. N. (2024) · Antibiotics · doi:10.3390/antibiotics13050436 · Cited by 32
Duplessis, C. A., You, D. M., Johnson, M. D., & Speziale, A. (2011) · Infection · doi:10.1007/s15010-011-0226-1 · Cited by 31
Clostridium difficile infection and intestinal microbiota interactions
Rodriguez, C., Taminiau, B., Broeck, J. V., Delmée, M., & Daube, G. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.10.018 · Cited by 34
Whittle, M. J., Bilverstone, T. W., van Esveld, R. J., Lücke, A.-C., Lister, M. M., Kuehne, S. A., & Minton, N. P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02295-21 · Cited by 34
Clostridium Difficile Infection in Patients with HIV/AIDS
Collini, P., Kuijper, E. J., & Dockrell, D. H. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0162-z · Cited by 32
“Recurrent CDI in particular is associated with large falls in Bacteroidetes and an overall decrease in phylotype richness compared with single episode CDI or control cases [7].”
BackgroundClostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment
Tang, Y. M., & Stone, C. D. (2017) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0719-2 · Cited by 33
“Markedly decreased microbial diversity has been demonstrated in patients who developed CDI, especially recurrent infection [12].”
BackgroundFecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile
Araos, R., Andreatos, N., Ugalde, J., Mitchell, S., Mylonakis, E., & D’Agata, E. M. C. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5030-7 · Cited by 29
Lee, K., Kim, M., & Lee, C. H. (2018) · Infection and Immunity · doi:10.1128/iai.00091-18 · Cited by 30
“Given that bacterial species within an ecosystem compete for resources (20), the observed decrease in gut micro-”
Stone, N. E., Nunnally, A. E., Jimenez, V. M., Jr., Cope, E. K., Sahl, J. W., Sheridan, K. L., Hornstra, H., Vinocur, J., Settles, E. W., Headley, K. C., et al. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.03.017 · Cited by 29
Coinfection and infection duration shape how pathogens affect the African buffalo gut microbiota
Sabey, K. A., Song, S. J., Jolles, A. E., Knight, R. D., & Ezenwa, V. O. (2020) · The ISME Journal · doi:10.1038/s41396-020-00855-0 · Cited by 29
Jan, N., Hays, R. A., Oakland, D. N., Kumar, P., Ramakrishnan, G., Behm, B. W., Petri, W. A., & Marie, C. S. (2021) · mSphere · doi:10.1128/msphere.00669-21 · Cited by 28
Suja Rani, S., Prajapati, J. B., Joshi, C. G., Sreeja, V., Gohel, M. K., Trivedi, S. S., Patel, R., Pandya, H. V., Singh, U. S., Phatak, A. G., et al. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00944 · Cited by 32
“, 2010), antibiotic-associated diarrhea (Chang et al., 2008), and Clostridium difficile infection (Seto et al.”
BackgroundFecal microbiota transplantation for Clostridium difficile infection: benefits and barriers
Lo Vecchio, A., & Cohen, M. B. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000023 · Cited by 27
“The fecal microbiome of patients with recurrent CDI displayed a marked and consistent decrease in diversity (phylotype richness) compared with healthy controls and those with initial CDI; a marked decrease in the phylum Bacteroidetes and Firmicutes was evident in recurrent CDI patients [19].”
ResultFecal microbiota transplantation: the state of the art
Di Bella, S., Drapeau, C., García-Almodóvar, E., & Petrosillo, N. (2013) · Infectious Disease Reports · doi:10.4081/idr.2013.e13 · Cited by 27
Freeman, J., Vernon, J. J., Vickers, R. J., & Wilcox, M. H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02000-15 · Cited by 27
“CDI recurrence is common following conventional antimicrobial treatment and is associated with reduced gut bacterial diversity (2).”
BackgroundAn Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection
Rao, K. K., Higgins, P., & Young, V. B. (2018) · mSphere · doi:10.1128/msphere.00033-18 · Cited by 29
Self-citationEnterotoxic Clostridia:Clostridioides difficileInfections
Mileto, S. J., Das, A., & Lyras, D. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0015-2018 · Cited by 28
“Following the ingestion of C. dif fi cile spores, infection may be established within the host upon spore germination and vegetative cell colonization of the colon (94).”
Sun, J., Li, M.-B., Tang, Z., Zhang, X., Chen, J., & Sun, Z. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14467 · Cited by 33
“An increase in Proteobacteria in humans has been reported Journal of Applied Microbiology 128, 54--64 © 2019 The Society for Applied Microbiology 61 to be related to inflammatory bowel diseases and recurrent Clostridium difficile infection (Chang et al. 2008; Packey and Sartor 2009).”
BackgroundLee, S., Jang, E. J., Jo, J., Park, S. J., & Ryu, H. G. (2021) · International Journal of Colorectal Disease · doi:10.1007/s00384-021-03886-x · Cited by 31
“Accordingly, given the reduced diversity of gut flora in patients with recurrent Clostridium difficile infection compared to firstepisode Clostridium difficile infection patients and healthy controls [34], host immunity and colonic flora disruption resulted from appendectomy may play a crucial role in recurrent Clostr…”
BackgroundLeelahavanichkul, A., Panpetch, W., Worasilchai, N., Somparn, P., Chancharoenthana, W., Nilgate, S., Finkelman, M., Chindamporn, A., & Tumwasorn, S. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw204 · Cited by 31
Thomason, C. A., Leon, A. E., Kirkpatrick, L. T., Belden, L. K., & Hawley, D. M. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13625 · Cited by 30
Understanding and Engineering Distributed Biochemical Pathways in Microbial Communities
Cao, X., Hamilton, J. J., & Venturelli, O. S. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01006 · Cited by 36
Metadata
- Authors
- Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B.
- Affiliations
- Michigan State University (US)
- Corresponding author
- Young, Vincent B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 197
- Issue
- 3
- Pages
- 435-438
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139607253
- Cited by
- 1,010
- References
- 15
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 36 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 69 · 2019: 59 · 2018: 107 · 2017: 78 · 2016: 77 · 2015: 88 · 2014: 87 · 2013: 78 · 2012: 53
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile, fecal microbiota, microbial diversity, antibiotic-associated diarrhea, 16S rRNA gene sequencing, bacterial community composition, dysbiosis, microbiota restoration
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Drug Administration Schedule, Enterocolitis, Pseudomembranous, Feces, Female, Humans, Male, Phylogeny, Recurrence, Reference Values, Genetic Variation, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.